Your browser doesn't support javascript.
loading
Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder.
Schmith, Virginia D; Curd, Laura; Lohmer, Lauren R L; Laffont, Celine M; Andorn, Anne; Young, Malcolm A.
Affiliation
  • Schmith VD; Nuventra Pharma Sciences, Durham, North Carolina, USA.
  • Curd L; Nuventra Pharma Sciences, Durham, North Carolina, USA.
  • Lohmer LRL; Nuventra Pharma Sciences, Durham, North Carolina, USA.
  • Laffont CM; Indivior Inc., Richmond, Virginia, USA.
  • Andorn A; Indivior Inc., Richmond, Virginia, USA.
  • Young MA; Indivior Inc., Richmond, Virginia, USA.
Clin Pharmacol Ther ; 106(3): 576-584, 2019 09.
Article in En | MEDLINE | ID: mdl-30801681
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Electrocardiography / Opiate Substitution Treatment / Opioid-Related Disorders Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2019 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Electrocardiography / Opiate Substitution Treatment / Opioid-Related Disorders Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Pharmacol Ther Year: 2019 Document type: Article Affiliation country: Estados Unidos